The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

Published:2016-05 Issue:5 Volume:21 Page:802-818
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Athauda Dilan,Foltynie Thomas

Funder

Michael J. Fox Foundation, Brain Research Trust, Cure Parkinson's Trust, Parkinson's UK

European Commission

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference255 articles.

1. Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies;Irwin;Nat. Rev. Neurosci.,2013

2. Incretin-based therapies for type 2 diabetes mellitus;Lovshin;Nat. Rev. Endocrinol.,2009

3. Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits;Drucker;Diabetes Care,2010

4. Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain;Heppner;Endocrinology,2015

5. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem;Alvarez;J. Neurochem.,2005

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principal components analysis on genes related to inflammasome complex and microglial activation in the hypothalamus of obese mice treated with semaglutide (GLP-1 analog);Brain Research;2025-01

2. Cross-talk between adipose tissue and microbiota-gut-brain-axis in brain development and neurological disorder;Brain Research;2024-12

3. Effect of GLP-1 receptor agonists on obesity in patients with severe mental illness: A state hospital case series of clozapine-treated patients;Psychiatry Research Case Reports;2024-12

4. Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease;European Journal of Pharmacology;2024-11

5. Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change;American Journal of Ophthalmology;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3